Human Papillomavirus-Induced Carcinogenesis with p53 Deficiency in Mouse: Novel Lymphomagenesis in HPV16E6E7 Transgenic Mice Mimicking p53 Defect

By Li Q.   Yoshioka N.   Yutsudo M.   Inafuku S.   Aozasa K.   Kitamura Y.   Aizawa S.   Nishimune Y.   Hakura A.   Kondoh G.  

Virology, Vol. 252, Iss. 1, 1998-12 ,pp. : 28-33

Elsevier

Access to resources Recommend Favorite

Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis

By Song S.   Liem A.   Miller J.A.   Lambert P.F.  

Virology, Vol. 267, Iss. 2, 2000-02 ,pp. : 141-150

Elsevier

Access to resources Recommend Favorite

Molecular analysis of episomal human papillomavirus type 16 DNA in a cervical carcinoma cell line

By Hall W.S.   Goto-Mandeville R.   Shih H.A.   Shank P.R.   Braun L.  

Virus Research, Vol. 51, Iss. 2, 1997-10 ,pp. : 183-195

Elsevier

Access to resources Recommend Favorite

Adenoassociated Virus Type 2-Induced Inhibition of the Human Papillomavirus Type 18 Promoter in Transgenic Mice

By Walz C.M.   Correa-Ochoa M.M.   Muller M.   Schlehofer J.R.  

Virology, Vol. 293, Iss. 1, 2002-02 ,pp. : 172-181

Elsevier

Access to resources Recommend Favorite

Effect of Preexisting Neutralizing Antibodies on the Anti-tumor Immune Response Induced by Chimeric Human Papillomavirus Virus-like Particle Vaccines

By Da Silva D.M.   Pastrana D.V.   Schiller J.T.   Kast W.M.  

Virology, Vol. 290, Iss. 2, 2001-11 ,pp. : 350-360

Elsevier

Access to resources Recommend Favorite